Fourth Volume of Popular eMultipleScleroris Review Series Launches for Clinicians

MANHATTAN, N.Y. - Feb. 7, 2022 - PRLog -- DKBmed, LLC, in collaboration with the Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing, is launching a fourth volume of its eMultipleSclerosis Review. This online literature review series curates the latest medical literature and explains how clinicians can apply the information presented in clinical practice. Volume 3 of eMultipleSclerosis Review was a resounding success, with over 6,000 participants, 4,500 app downloads, and over 7,000 page views - 96% of participants reported knowledge gains, with 69% noting that they intended to change their practice based on the information they learned.

The program can be found at emultiplesclerosisreview.org (https://elit.dkbmed.com/programs/1)

Multiple sclerosis is estimated to affect approximately 2.1 million people worldwide. With no known cure, MS is a lifelong condition that ranks second behind congestive heart failure in direct, all-cause medical costs. While the search for curative treatments continues, multiple disease-modifying treatments (DMTs) have emerged in recent years to treat patients with relapsing-remitting MS (RRMS). People with progressive forms of MS have fewer DMT options.

"The treatment of multiple sclerosis is continually evolving, and the growing amount of literature on the disease is overwhelming, even for the most diligent of clinicians" notes Joseph Sabatino, Jr., MD, PhD, Assistant Adjunct Professor, Department of Neurology at University of California San Francisco and guest author of eMultipleSclerosis Review. "A resource like eMultipleSclerosis Review is very helpful for clinicians, and I'm pleased that there will be future activities to help stay up to date on the latest developments in MS."

Volume 4 of the eMultipleSclerosis Review will cover pertinent topics in the care of patients with MS, including:

• The effects of different DMTs on COVID-19 vaccine response
• Nonpharmacologic approaches to symptom management
• Newly approved and emerging therapies demonstrating promise in clinical trials
• Optimizing management of MS in older populations
• Recent advances in minimizing and preventing misdiagnoses of MS
• Caring for patients from different racial and ethnic backgrounds

eMultipleSclerosis Review is one component of the highly successful and popular eLiterature Review series published through DKBmed's collaboration with the Johns Hopkins School of Medicine and the Institute for Johns Hopkins Nursing. Each installment consists of a newsletter and podcast. To view this and similar learning programs centered on other conditions, including cystic fibrosis, HIV, and COPD, visit elit.dkbmed.com (https://elit.dkbmed.com/programs/1).